Prediction of Rehospitalization Following a Sepsis Admission Using a Wearable Biopatch
Prediction of Rehospitalization Following a Sepsis Admission Using a Wearable Biopatch and Deep Learning Model
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: Age \>= 18 years Development of sepsis, defined by recent international guidelines (Suspected infection AND 2-point change in sequential organ failure assessment (SOFA) score), in emergency department or hospital Admission to hospital from emergency department Exclusion Criteria: Transition to comfort measures within 6 hours of time of sepsis Discharge from the emergency department Admission to bone marrow transplant service Severe burn or other dermatologic condition that will prevent application to skin
About the study
The goal of this observational study is to learn about the utility of biopatches predicting 30-day readmissions in patients discharged from the hospital with sepsis.
The main question\[s\] it aims to answer are:
• Does the application of a biopatch provide data that can improve prediction of an unplanned 30-day readmission following a hospitalization for sepsis.
Participants will be asked to wear a biopatch on their chest for 30-days following hospital discharge or until readmission to the hospital.
What is being tested
- BioIntellisense (device)
Sponsor: University of California, San Diego · Participants: 200 · Started: May 1, 2023
Contact the study team
- Gabriel Wardi · Phone: 6195436463
Official record on ClinicalTrials.gov — NCT05806762
Locations in the U.S.
| California | UC San Diego Health, San Diego |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.